Annual Retained Earnings
$590.01 M
+$271.40 M+85.19%
December 31, 2022
Summary
- As of March 14, 2025, HZNP annual retained earnings is $590.01 million, with the most recent change of +$271.40 million (+85.19%) on December 31, 2022.
- During the last 3 years, HZNP annual retained earnings has risen by +$1.20 billion (+197.41%).
Performance
HZNP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
$771.76 M
+$127.07 M+19.71%
June 30, 2023
Summary
- As of March 14, 2025, HZNP quarterly retained earnings is $771.76 million, with the most recent change of +$127.07 million (+19.71%) on June 30, 2023.
- Over the past year, HZNP quarterly retained earnings has increased by +$187.92 million (+32.19%).
Performance
HZNP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
HZNP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +85.2% | +32.2% |
| 3 y3 years | +197.4% | +210.4% |
| 5 y5 years | +147.5% | +153.6% |
HZNP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -46.0% | at high | -58.7% |
| 5 y | 5-year | at high | -202.7% | at high | -190.6% |
| alltime | all time | at high | -310.5% | at high | -286.7% |
Horizon Therapeutics Public Limited Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $771.76 M(+19.7%) |
| Mar 2023 | - | $644.69 M(+9.3%) |
| Dec 2022 | $590.01 M(+85.2%) | $590.01 M(-2.7%) |
| Sep 2022 | - | $606.28 M(+3.8%) |
| Jun 2022 | - | $583.84 M(+11.7%) |
| Mar 2022 | - | $522.87 M(+64.1%) |
| Dec 2021 | $318.61 M(-247.6%) | $318.61 M(+119.1%) |
| Sep 2021 | - | $145.42 M(-180.3%) |
| Jun 2021 | - | -$181.12 M(-46.6%) |
| Mar 2021 | - | -$339.24 M(+57.1%) |
| Dec 2020 | -$215.89 M(-64.4%) | -$215.89 M(-46.9%) |
| Sep 2020 | - | -$406.44 M(-41.9%) |
| Jun 2020 | - | -$699.28 M(+12.9%) |
| Mar 2020 | - | -$619.27 M(+2.2%) |
| Dec 2019 | -$605.68 M(-48.6%) | -$605.68 M(-49.5%) |
| Sep 2019 | - | -$1.20 B(-1.5%) |
| Jun 2019 | - | -$1.22 B(+0.4%) |
| Mar 2019 | - | -$1.21 B(+2.8%) |
| Dec 2018 | -$1.18 B(-5.1%) | -$1.18 B(-16.7%) |
| Sep 2018 | - | -$1.41 B(-1.8%) |
| Jun 2018 | - | -$1.44 B(+2.3%) |
| Mar 2018 | - | -$1.41 B(+13.4%) |
| Dec 2017 | -$1.24 B(+46.5%) | -$1.24 B(+3.0%) |
| Sep 2017 | - | -$1.21 B(+5.6%) |
| Jun 2017 | - | -$1.14 B(+22.6%) |
| Mar 2017 | - | -$931.38 M(+9.8%) |
| Dec 2016 | -$848.02 M | -$848.02 M(+18.2%) |
| Sep 2016 | - | -$717.48 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | -$711.61 M(-2.1%) |
| Mar 2016 | - | -$726.59 M(+6.7%) |
| Dec 2015 | -$681.19 M(-5.5%) | -$681.19 M(-3.4%) |
| Sep 2015 | - | -$705.18 M(-0.5%) |
| Jun 2015 | - | -$708.46 M(-4.3%) |
| Mar 2015 | - | -$740.27 M(+2.7%) |
| Dec 2014 | -$720.72 M(+57.7%) | -$720.72 M(+4.6%) |
| Sep 2014 | - | -$689.07 M(-0.3%) |
| Jun 2014 | - | -$691.13 M(+4.2%) |
| Mar 2014 | - | -$663.37 M(+45.1%) |
| Dec 2013 | -$457.12 M(+48.4%) | -$457.12 M(+29.1%) |
| Sep 2013 | - | -$354.21 M(+1.6%) |
| Jun 2013 | - | -$348.72 M(+5.6%) |
| Mar 2013 | - | -$330.28 M(+7.2%) |
| Dec 2012 | -$308.11 M(+39.8%) | -$308.11 M(+8.6%) |
| Sep 2012 | - | -$283.78 M(+6.4%) |
| Jun 2012 | - | -$266.82 M(+9.3%) |
| Mar 2012 | - | -$244.04 M(+10.8%) |
| Dec 2011 | -$220.32 M(+105.8%) | -$220.32 M(+53.4%) |
| Sep 2011 | - | -$143.59 M(+13.6%) |
| Jun 2011 | - | -$126.36 M(+10.1%) |
| Mar 2011 | - | -$114.72 M(+7.2%) |
| Dec 2010 | -$107.05 M(+33.8%) | -$107.05 M(+9.0%) |
| Sep 2010 | - | -$98.23 M(+14.5%) |
| Jun 2010 | - | -$85.83 M(-2.4%) |
| Mar 2010 | - | -$87.89 M(+9.9%) |
| Dec 2009 | -$79.99 M(+34.5%) | -$79.99 M |
| Dec 2008 | -$59.49 M | - |
FAQ
- What is Horizon Therapeutics Public Limited annual retained earnings?
- What is the all time high annual retained earnings for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited annual retained earnings year-on-year change?
- What is Horizon Therapeutics Public Limited quarterly retained earnings?
- What is the all time high quarterly retained earnings for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly retained earnings year-on-year change?
What is Horizon Therapeutics Public Limited annual retained earnings?
The current annual retained earnings of HZNP is $590.01 M
What is the all time high annual retained earnings for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual retained earnings is $590.01 M
What is Horizon Therapeutics Public Limited annual retained earnings year-on-year change?
Over the past year, HZNP annual retained earnings has changed by +$271.40 M (+85.19%)
What is Horizon Therapeutics Public Limited quarterly retained earnings?
The current quarterly retained earnings of HZNP is $771.76 M
What is the all time high quarterly retained earnings for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly retained earnings is $771.76 M
What is Horizon Therapeutics Public Limited quarterly retained earnings year-on-year change?
Over the past year, HZNP quarterly retained earnings has changed by +$187.92 M (+32.19%)